CY1104995T1 - Διεργασια και εστερικα παραγωγα χρησιμα στην παρασκευη κεφαλοσπορινων - Google Patents

Διεργασια και εστερικα παραγωγα χρησιμα στην παρασκευη κεφαλοσπορινων

Info

Publication number
CY1104995T1
CY1104995T1 CY20061100361T CY061100361T CY1104995T1 CY 1104995 T1 CY1104995 T1 CY 1104995T1 CY 20061100361 T CY20061100361 T CY 20061100361T CY 061100361 T CY061100361 T CY 061100361T CY 1104995 T1 CY1104995 T1 CY 1104995T1
Authority
CY
Cyprus
Prior art keywords
cephalosporins
preparation
ester derivatives
derivatives useful
useful
Prior art date
Application number
CY20061100361T
Other languages
English (en)
Inventor
J. C. Colberg
J. L. Tucker
M. Zenoni
Giovanni Fogliato
Alessandro Donadelli
Isao Nagakura
Hiromasa Morita
Hideyuki Matsuo
Original Assignee
Pfizer Products Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Incorporated filed Critical Pfizer Products Incorporated
Publication of CY1104995T1 publication Critical patent/CY1104995T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/08—Preparation by forming the ring or condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Αυτή η εφεύρεση είναι σχετική με μία διεργασία παραγωγής μίας ενώσεως του τύπου (I) όπου το R1 είναι παρα-νιτροβενζύλιο ή αλλύλιο, και το Χ είναι αλογόνο, η οποία είναι χρήσιμη στην παραγωγή 3-κυκλικών αιθεροϋποκατεστημένων καφαλοσπορινών, από τριμεθυλοφωσφινικές ενώσεις. Αυτή η εφεύρεση, είναι επίσης σχετική με ενώσεις χρήσιμες σε μία τέτοια διεργασία.
CY20061100361T 2000-12-04 2006-03-15 Διεργασια και εστερικα παραγωγα χρησιμα στην παρασκευη κεφαλοσπορινων CY1104995T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25101800P 2000-12-04 2000-12-04
PCT/IB2001/002181 WO2002046199A1 (en) 2000-12-04 2001-11-19 Process and ester derivatives useful for preparation of cephalosporins

Publications (1)

Publication Number Publication Date
CY1104995T1 true CY1104995T1 (el) 2009-11-04

Family

ID=22950131

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100361T CY1104995T1 (el) 2000-12-04 2006-03-15 Διεργασια και εστερικα παραγωγα χρησιμα στην παρασκευη κεφαλοσπορινων

Country Status (24)

Country Link
US (2) US20020099205A1 (el)
EP (1) EP1339723B1 (el)
JP (1) JP2004515503A (el)
KR (1) KR100526380B1 (el)
CN (1) CN1243756C (el)
AR (1) AR035076A1 (el)
AT (1) ATE319719T1 (el)
AU (2) AU2392902A (el)
BR (1) BR0115872A (el)
CA (1) CA2436863C (el)
CY (1) CY1104995T1 (el)
CZ (1) CZ20031526A3 (el)
DE (1) DE60117876T2 (el)
DK (1) DK1339723T3 (el)
ES (1) ES2257471T3 (el)
HK (1) HK1059265A1 (el)
HU (1) HUP0400686A3 (el)
IL (1) IL155701A0 (el)
MX (1) MXPA03004938A (el)
PL (1) PL362078A1 (el)
PT (1) PT1339723E (el)
RU (1) RU2237671C1 (el)
WO (1) WO2002046199A1 (el)
ZA (1) ZA200303498B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03004937A (es) * 2000-12-04 2003-09-10 Pfizer Prod Inc Procedimiento de acoplamiento e intermedios utiles para preparar cefalosporinas.
RU2321590C1 (ru) * 2004-03-09 2008-04-10 Пфайзер Продактс Инк. Способ получения промежуточных соединений цефалоспорина с использованием сложных эфиров альфа-йод-1-азетидинуксусной кислоты и триалкилфосфитов
KR100830754B1 (ko) * 2004-03-09 2008-05-19 화이자 프로덕츠 인코포레이티드 α-요오도-1-아제티딘아세트산 에스테르 및 트라이알킬포스파이트를 이용한 세팔로스포린 중간체의 제조방법
EP1951723B1 (en) 2005-10-20 2017-08-30 Postech Academy-Industry Foundation The application using non-covalent bond between a cucurbituril derivative and a ligand
CN102372738B (zh) * 2010-08-14 2017-11-10 武汉工程大学 Lj反应在制备维蒂希试剂和草铵膦中的应用
CN105254648B (zh) * 2015-11-13 2018-04-03 广东温氏大华农生物科技有限公司 一种头孢维星及其钠盐的合成方法
GB2575261B (en) 2018-07-02 2022-03-09 Norbrook Lab Ltd Intermediates in the synthesis of C3-substituted cephalosporins
CN111892612A (zh) * 2020-07-31 2020-11-06 重庆医药高等专科学校 一种以青霉素钾盐为原料制备头孢维星的中间体异构化物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001997A (en) * 1990-07-24 1999-12-14 Bateson; John Hargreaves Cephalosporins and homologues, preparations and pharmaceutical compositions
US6020329A (en) * 1990-07-24 2000-02-01 Pzifer Inc. Cephaloporins and homologues, preparations and pharmaceutical compositions
MY106399A (en) * 1990-07-24 1995-05-30 Pfizer Cephalosporins and homologeus, preparation and pharmaceutical composition
GB9212609D0 (en) * 1992-06-13 1992-07-29 Smithkline Beecham Plc Novel compounds
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation

Also Published As

Publication number Publication date
AU2002223929B2 (en) 2007-08-23
KR20030070044A (ko) 2003-08-27
ZA200303498B (en) 2004-05-07
HUP0400686A2 (hu) 2004-06-28
AU2392902A (en) 2002-06-18
HK1059265A1 (en) 2004-06-25
US20040267008A1 (en) 2004-12-30
CA2436863A1 (en) 2002-06-13
WO2002046199A1 (en) 2002-06-13
EP1339723B1 (en) 2006-03-08
PL362078A1 (en) 2004-10-18
CN1243756C (zh) 2006-03-01
KR100526380B1 (ko) 2005-11-08
ATE319719T1 (de) 2006-03-15
ES2257471T3 (es) 2006-08-01
WO2002046199A8 (en) 2003-06-12
CN1478094A (zh) 2004-02-25
BR0115872A (pt) 2003-10-28
AR035076A1 (es) 2004-04-14
IL155701A0 (en) 2003-11-23
CZ20031526A3 (en) 2004-04-14
DE60117876T2 (de) 2006-08-31
US20020099205A1 (en) 2002-07-25
JP2004515503A (ja) 2004-05-27
MXPA03004938A (es) 2003-09-10
HUP0400686A3 (en) 2010-03-29
CA2436863C (en) 2007-05-22
RU2237671C1 (ru) 2004-10-10
DK1339723T3 (da) 2006-06-12
PT1339723E (pt) 2006-06-30
DE60117876D1 (de) 2006-05-04
EP1339723A1 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
CY1104995T1 (el) Διεργασια και εστερικα παραγωγα χρησιμα στην παρασκευη κεφαλοσπορινων
CY1113487T1 (el) Νεα παραγωγα μανδελικου οξεος και η χρηση τους ως αναστολεις θροβινης
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
CY1107503T1 (el) Αντιβιοτικα διπλης δρασης
PT810209E (pt) Hidroxietilamino-sulfonamidas de alfa- e beta-aminoacidos uteis como inibidores de protease retroviral
FI924397A (fi) Substituerade pyrimidiner
ES2088537T3 (es) Derivados de piranil cianoguanidina.
CY1111876T1 (el) Νεες πυρρολες με υπολiπiδaiμiκες και υποχοληστερολαιμικες δραστικοτητες, μεθοδος για την παρασκευη αυτων και φαρμακευτικες συνθεσεις που τις περιεχουν και η χρηση αυτων στην ιατρικη
DE69821985D1 (de) Ortho-anthranilamide derivate als antikoagulantien
CY1108398T1 (el) Διαδικασια και ενδιαμεσα για την παραγωγη 7-υποκατεστημενων αντιοιστρογονων
EA200200940A1 (ru) Производные азетидина, способ их получения и содержащие их фармацевтические композиции
ES2147411T3 (es) Derivados de triazolopirimidina.
CY1108041T1 (el) Αναστολεις της rho-κινασης
CY1106890T1 (el) Παραγωγα της ακριδινης και η χρηση τους ως φαρμακων
DE60107449D1 (de) Substituierte aminopropoxyarylderivate als lxr agonisten
FI913478A0 (fi) Diazinderivat.
PT923554E (pt) N-benzilpiperidina e derivados tetrahidropiridina
DK506587D0 (da) Imidderivater
CY1110377T1 (el) Ανδρογονα 7-υποκατεστημενα 11-αλογονουχα στεροειδη
ATE181066T1 (de) Zwischenverbindungen zur herstellung von thioalkylthio cephalosporinderivaten
ES2157199T3 (es) Nuevo procedimiento para la produccion de cefalosporinas y nuevos compuestos intermedios para este procedimiento.
ATE453389T1 (de) Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen
FI882358A0 (fi) Cykliska antikoagulationspeptider.
FI882359A (fi) Cykliska antikoagulationspeptider. pi path slues6208 s880524 mlues6205 m881102
CY1105550T1 (el) Μεμνο-πεπτιδια, μια διαδικασια για την παρασκευη και τη χρηση τους